a Learning Key Laboratory for Pharmacoproteomics of Hunan Province, Institute of Pharmacy and Pharmacology, University of South China , Henyang , China.
b Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery System, Hunan University of Medicine , Huaihua , China.
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1476-1487. doi: 10.1080/21691401.2019.1601104.
Polymeric micelles (PMs) play a vital role in multidrug co-delivery and cancer treatment. However, the development of intelligent PMs further allows PMs to accurately -target tumour, selectively release cargo multidrug and increase uptake. Therefore, targets, controlled release and uptake of intelligent PMs should be paid more attention to improvement synergistic therapeutic outcomes and minimize side effects. In this review, tumour targeting of co-delivery intelligent PMs and its intracellular trafficking mechanisms were overviewed. And this review provides a comprehensive summarization of several intelligent co-delivery PMs. Such a system could control the multidrug to be released simultaneously or sequentially by special properties of tumour microenvironment (TME) (including acidic PH, redox, overexpressed enzyme, excessive temperature) and external environment trigger. Additionally, limitations, clinical translation and future perspectives of intelligent co-delivery PMs were also being discussed in this article.
聚合物胶束(PMs)在多药共递和癌症治疗中起着至关重要的作用。然而,智能 PMs 的发展进一步使得 PMs 能够精确靶向肿瘤,选择性释放多药货物并增加摄取。因此,应更加关注智能 PMs 的靶向、控制释放和摄取,以提高协同治疗效果并最小化副作用。在这篇综述中,综述了共递智能 PMs 的肿瘤靶向及其细胞内转运机制。本文还对几种智能共递 PMs 进行了全面总结。该系统可以通过肿瘤微环境(TME)(包括酸性 PH、氧化还原、过表达酶、过高温度)和外部环境触发的特殊性质来控制多药物的同时或顺序释放。此外,本文还讨论了智能共递 PMs 的局限性、临床转化和未来展望。